Advertisement
News
Advertisement

Spencer Pharma to co-develop nervous system disease treatments

Mon, 11/01/2010 - 11:41am
Mass High Tech: The Journal of New England Technology

Spencer Pharmaceutical Inc., a Boston drug development firm focused on metabolic disease treatments, has formed an agreement with National Pharmaceutical Corp. to co-develop treatments for Alzheimer’s and Parkinson’s disease.

According to terms of the agreement, the two companies will use a drug delivery platform developed by Spencer to create central nervous disease therapeutics.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading